Description

The Hepatic Fibrosis Test YRA317 // YRA321 offers a crucial diagnostic solution for early detection and monitoring of liver fibrosis. By using advanced chemiluminescence immunoassay technology, this test provides precise measurements, helping healthcare professionals reverse or delay the progress of hepatic fibrosis into cirrhosis, thus improving patient outcomes. Compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, this test ensures seamless integration into existing laboratory workflows.

Market Price

The Hepatic Fibrosis Test YRA317 // YRA321 is competitively priced in the market, with costs typically ranging between $150 to $300 per box, depending on the supplier and purchasing volume. For personalized pricing, consider utilizing Kalstein Plus for an instant quotation tailored to your specific needs.

Frequently Asked Questions

What are the main parameters tested by this product? The test measures specific markers such as PIIINP, CIV, LN, HA, and CG, crucial for assessing liver fibrosis.

Is the test compatible with all CLIA analyzers? It is specifically designed to work with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390.

Advantages and Disadvantages

The primary advantage of the Hepatic Fibrosis Test YRA317 // YRA321 is its ability to provide early and accurate detection of liver fibrosis, facilitating timely intervention. A potential downside is the need for specific equipment, such as the designated CLIA analyzers, which may not be available in all medical settings.

Product Usage in the Field

In practical settings, the Hepatic Fibrosis Test YRA317 // YRA321 is used in hospital laboratories and specialized medical facilities to evaluate liver health, particularly for patients at risk of fibrotic conditions. Regular use aids in monitoring disease progression and the effectiveness of therapeutic interventions.

Recommendations

To ensure optimal performance of the Hepatic Fibrosis Test YRA317 // YRA321, always store the product at 2-8°C. Regular calibration with 2/6 points is recommended for maintaining accuracy. As part of your laboratory’s quality control process, consider scheduling regular maintenance of your analyzers.

Features

• Accurate and early detection of hepatic fibrosis
• Compatible with select CLIA analyzers
• Available in multiple packaging sizes
• Certified with CE, ISO13485, and FSC

Technical Specifications